Rel/NF-κB and IκB proteins: An overview

Seminars in Cancer Biology

Volumn 8, Issue 2, 1997, Pages 63-73

  May, Michael J ^a   Ghosh, Sankar ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA binding proteins; I B; NF B; Rel proteins; Transcription factors

Indexed keywords

ANKYRIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR;

CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CYTOPLASM; DNA SEQUENCE; DNA TRANSCRIPTION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION;

EID: 0031126702     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1997.0057     Document Type: Article

References (113)

1. 1. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716
2. 2. Sen R, Baltimore D (1986) Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921-928
3. 3. Kunsch C, Ruben S, Rosen C (1992) Selection of optimal κB-Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 12:4412-4421
4. 4. Parry GC, Mackman N (1994) A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 269:20823-20825
5. 5. Grilli M, Chiu JJ-S, Lenardo M (1993) NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 143:1-62
6. 6. Kopp E, Ghosh S (1995) NF-κB and rel proteins in innate immunity. Adv Immunol 58:1-27
7. 7. Kawakami K, Scheidereit C, Roeder RG (1988) Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci USA 85:4700-4704
8. 2+ dependence, and differential half-site recognition. J Biol Chem 266:252-260
9. 9. Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan GP, Baltimore D (1990) Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029
10. 10. Baeuerle PA, Baltimore D (1989) A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev 3:1689-1698
11. 11. Urban M, Schrev R, Baeuerle P (1991) NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J 10:1817-1825
12. 12. Ip YT, Reach M, Engstrom Y, Kadalayil L, Cai H, Gonzalez-Crespo S, Tatei K, Levine M (1993) Dif, a dorsal-related gene that mediates an immune response in Drosophila. Cell 75:753-763
13. 13. Stephens RM, Rice NR, Hiebsch RR, Bose HR Jr, Gilden RV (1983) Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus. Proc Natl Acad Sci USA 80:6229-6233
14. 14. Wilhelmsen KC, Eggleton K, Temin HM (1984) Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J Virol 52:172-182
15. 15. Steward R (1987) Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene c-rel. Science 259:1912-1915
16. 16. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O, Urban MB, Kourilsky P, Baeuerle PA, Israël A (1990) The DNA binding subunit of NF-κB is identical to factor KBF 1 and homologous to the rel oncogene product. Cell 62:1007-1018
17. 17. Nolan G, Ghosh S, Liou H-C, Tempst P, Baltimore D (1991) DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969
18. 18. Ruben S, Dillon P, Schreck R, Henkel T, Chen C, Maher M, Baeuerle P, Rosen C (1991) Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251:1490-1493
19. 19. Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ (1991) Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature 352:733-736
20. 20. Ruben SM, Klement JF, Coleman TA, Maher M, Chen CH, Rosen CA (1992) I-Rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Genes Dev 6:745-760
21. 21. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AA, Chaganti RS, Dalla-Favera R (1991) B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087
22. 22. Ryseck R-P, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R (1992) RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol Cell Biol 12:674-684
23. 23. Phillips RJ, Gustafson S, Ghosh S (1996) Identification of a novel NF-κB p50-related protein in B lymphocytes. Mol Cell Biol 16:7089-7097
24. 24. Liou HC, Sha WC, Scott ML, Baltimore D (1994) Sequential induction of NF-κB/ Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 14:5349-5359
25. 25. Miyamoto S, Chiao P, Verma I (1994) Enchanced IκB-α degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol Cell Biol 14:3276-3282
26. 26. Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE (1995) Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 181:1169-1177
27. 27. Molitor JA, Walker WH, Doerre S, Ballard DW, Greene WC (1990) NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 87:10028-10032
28. 28. Ganchi PA, Sun SC, Greene WC, Ballard DW (1993) A novel NF-κB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol 13:7826-7835
29. 29. Hansen SK, Baeuerle PA, Blasi F (1994) Purification, reconstitution, and IκB association of the c-Rel-p65 (RelA) complex, a strong activator of transcription. Mol Cell Biol 14:2593-2603
30. 30. Kang SM, Tran AC, Grilli M, Lenardo MJ (1992) NF-κB subunit regulation in nontransformed CD4+ T lymphocytes. Science 256:1452-1456
31. 31. Ryseck R-P, Novotny J, Bravo R (1995) Characterization of elements determining the dimerization properties of RelB and p50. Mol Cell Biol 15:3100-3109
32. 32. Lernbecher T, Kistler B, Wirth T (1994) Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J 13:4060-4069
33. 33. Dobrzanski P, Ryseck R-P, Bravo R (1995) Specific inhibition of RelB/ p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10:1003-1007
34. 34. Olashaw NE (1996) Inducible activation of RelB in fibroblasts. J Biol Chem 271:30307-30310
35. 35. Bull P, Morley KL, Hoekstra MF, Hunter T, Verma IM (1990) The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol Cell Biol 10:5473-5485
36. 36. Schmitz ML, Baeuerle PA (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 10:3805-3817
37. 37. Schmitz ML, dos Santos Silva MA, Altmann H, Czisch M, Holak TA, Baeuerle PA (1994) Structural and functional analysis of the NF-κB p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J Biol Chem 269:25613-25620
38. 38. Blair WS, Bogerd HP, Madore SJ, Cullen BR (1994) Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module. Mol Cell Biol 14:7226-7234
39. 39. Schmitz ML, Stelzer G, Altmann H, Meisterernst M, Baeuerle PP (1995) Interaction of the COOH-terminal transactivation domain of p65 NF-κB with TATA-binding protein, transcription factor IIB, and coactivators. J Biol Chem 270:7219-7226
40. 40. Dobrzanski P, Ryseck R-P, Bravo R (1993) Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol Cell Biol 13:1572-1582
41. 41. Lernbecher T, Muller U, Wirth T (1993) Distinct NF-κB/ Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770
42. 42. Plaksin D, Baeuerle PA, Eisenbach L (1993) KBF1 (p50 NF-κB homodimer) acts as a represser of H-2Kb gene expression in metastatic tumor cells. J Exp Med 177:1651-1662
43. 43. Brown A, Linhoff M, Stein B, Wright K, Baldwin A, Basta P, Ting J (1994) Function of NF-κB/ Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-κB/ Rel subunits. Mol Cell Biol 14:2926-2935
44. 44. Fujita T, Nolan GP, Ghosh S, Baltimore D (1992) Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev 6:775-787
45. 45. Lin R, Gewert D, Hiscott J (1995) Differential transcriptional activation in vitro by NF-κB/ Rel proteins. J Biol Chem 270:3123-3131
46. 46. Wulczyn FG, Naumann M, Scheidereit C (1992) Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358:597-599
47. 47. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/ NF-κB-mediated inhibition. Nature 359:339-342
48. 48. Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi M, Kanno T, Brown K, Siebenlist U (1993) The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J 12:3893-3901
49. 49. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U (1993) The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739
50. 50. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 7:1354-1363
51. 51. Nolan GP, Fujita T, Bhatia K, Huppi C, Liou HC, Scott ML, Baltimore D (1993) The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 13:3557-3566
52. 52. Rice NR, MacKichan ML, Israël A (1992) The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253
53. 53. Mercurio F, DiDonato JA, Rosette C, Karin M (1993) p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev 7:705-718
54. 54. Dushay MS, Åsling B, Hultmark D (1996) Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc Natl Acad Sci USA 93:10343-10347
55. 55. Fan CM, Maniatis T (1991) Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354:395-398
56. 56. Naumann M, Scheidereit C (1994) Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J 13:4597-4607
57. 57. Palombella V, Rando O, Goldberg A, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785
58. 58. Lin L, Ghosh S (1996) A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol 16:2248-2254
59. 59. Betts JC, Nabel GJ (1996) Differential regulation of NF-κB2(p100) processing and control by amino-terminal sequences. Mol Cell Biol 16:6363-6371
60. 60. Baeuerle PA, Baltimore D (1988) IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546
61. 61. Ghosh S, Baltimore D (1990) Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682
62. 62. Zabel U, Baeuerle PA (1990) Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61:255-265
63. 63. Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS Jr (1991) Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289
64. 64. Davis N, Ghosh S, Simmons DL, Tempst P, Liou HC, Baltimore D, Bose HR Jr (1991) Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science 253:1268-1271
65. 65. Breeden L, Nasmyth K (1987) Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature 329:651-654
66. 66. Inoue J, Kerr L, Kakizuka A, Verma I (1992) IκBγ, a 70kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109-1120
67. 67. Grumont RJ, Gerondakis S (1994) Alternative splicing of RNA transcripts encoded by he murine p105 NF-κB gene generates IκBγ isoforms with different inhibitory activities. Proc Natl Acad SCi USA 91:4367-4371
68. 68. Ray P, Zhang DH, Elias JA, Ray A (1995) Cloning of a differentially expressed IκB-related protein. J Biol Chem 270:10680-10685
69. 69. Thompson J, Phillips R, Erdjument-Bromage H, Tempst P, Ghosh S (1995) IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582
70. 70. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS Jr (1992) IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev 6:1899-1913 [published erratum appears in Genes Dev 1992 Dec;6(12B):2664-2665]
71. 71. Ganchi PA, Sun SC, Greene WC, Ballard DW (1992) IκB/ MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol Biol Cell 3:1339-1352
72. 72. Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C (1992) The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc Natl Acad Sci 89:2489-2493
73. 73. Inoue J, Kerr LD, Rashid D, Davis N, Bose HR Jr, Verma IM (1992) Direct association of pp40/ IκBβ with rel/ NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci USA 89:4333-4337
74. 74. Zhang Q, Didonato J, Karin M, McKeithan T (1994) BCL3 encodes a nuclear protein which can alter the subcellular location of NF-κB proteins. Mol Cell Biol 14:3915-3926
75. 75. Suyang H, Phillips RJ, Douglas I, Ghosh S (1996) Role of unphosphorylated, newly synthesized IκB-β in persistent activation of NF-κB. Mol Cell Biol 16:5444-5449
76. 76. Henkel T, Zabel U, van Zee K, Muller JM, Fanning E, Baeuerle PA (1992) Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68:1121-1133
77. 77. Zabel U, Henkel T, Silva MS, Baeuerle PA (1993) Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 12:201-211
78. 78. Leveillard T, Verma IM (1993) Diverse molecular mechanisms of inhibition of NF-κB/ DNA binding complexes by IκB proteins. Gene Exp 3:135-150
79. 79. Dobrzanski P, Ryseck R-P, Bravo R (1994) Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J 13:4608-4616
80. 80. Ernst M, Dunn L, Rice N (1995) The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol Cell Biol 15:872-882
81. 81. Jaffray E, Wood KM, Hay HT (1995) Domain organization of IκBα and sites of interaction with NF-κB p65. Mol Cell Biol 15:2166-2172
82. 82. Beauparlant P, Lin R, Hiscott J (1996) The role of the C-terminal domain of IκBα in protein degradation and stabilization. J Biol Chem 271:10690-10696
83. 83. Chu Z, McKinsey TA, Liu L, Qi X, Ballard DW (1996) Basal phosphorylation o the PEST domain in IκB-β regulates its functional interaction with the c-rel proto-oncogene product. Mol Cell Biol 16:5974-5984
84. 84. Grimm S, Baeuerle PA (1993) The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem J 290:297-308
85. 85. Kunsch C, Rosen C (1993) NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13:6137-6146
86. 86. Hansen SK, Nerlov C, Zabel U, Verde P, Johnsen M, Baeuerle PA, Blasi F (1992) A novel complex between the p65 subunit of NF-κB and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J 11:205-213
87. 87. Hansen SK, Guerrini L, Blasi F (1994) Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. J Biol Chem 269:22230-22237
88. 88. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, Mackman N (1994) Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/ p65 heterodimers to a κB-like site. Mol Cell Biol 14:3772-3781
89. 89. Logeat F, Israël N, Ten R, Blank V, Le Bail O, Kourilsky P, Israël A (1991) Inhibition of transcription factors belonging to the rel/ NF-κB family by a transdominant negative mutant. EMBO J 10:1827-1832
90. 90. Toledano MB, Ghosh D, Trinh F, Leonard WJ (1993) N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-κB p50 and p65. Mol Cell Biol 13:852-860
91. 91. Coleman TA, Kunsch C, Maher M, Ruben SM, Rosen CA (1993) Acquisition of NFKB1-selective DNA binding by substitution of four amino acid residues from NFKB1 into RelA. Mol Cell Biol 13:3850-3859
92. 92. Bressler P, Brown K, Timmer W, Bours V, Siebenlist U, Fauci AS (1993) Mutational analysis of the p50 subunit of NF-κB and inhibition of NF-κB activity by trans-dominant p50 mutants. J Virol 67:288-293
93. 93. Ruben SM, Narayanan R, Klement JF, Chen CH, Rosen CA (1992) Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol 12:444-454
94. c-rel. Mol Cell Biol 11:5867-5877
95. 95. Norris JL, Manley JL (1992) Selective nuclear transport of the Drosophila morphogen dorsal can be established by a signaling pathway involving the transmembrane protein Toll and protein kinase A. Genes Dev 6:1654-1667
96. 96. Li CC, Korner M, Ferris DK, Chen E, Dai RM, Longo DL (1994) NF-κB/ Rel family members are physically associated phosphoproteins. Biochem J 303:499-506
97. 97. Li CC, Dai RM, Chen E, Longo DL (1994) Phosphorylation of NF-KB1-p50 is involved in NF-κB activation and stable DNA binding. J Biol Chem 269:30089-3092
98. 98. Ghosh G, van Duyne G, Ghosh S, Sigler PB (1995) Structure of NF-κB p50 homodimer bound to a κB site. Nature 373:303-310
99. 99. Müller CW, Harrison SC (1995) The structure of the NF-κB p50:DNA-complex: a starting point for analyzing the Rel family. FEBS Lett 369:113-117
100. 100. Thanos D, Maniatis T (1992) The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus indiction of the human IFN-β gene. Cell 71:777-789
101. 101. Müller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC (1995) Structure of the NF-κB p50 homodimer bound to DNA. Nature 373:311-317
102. 102. Kerr LD, Ransone LJ, Wamsley P, Schmitt MJ, Boyer TG, Zhou Q, Berk AJ, Verma IM (1993) Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature 365:412-419
103. 103. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GH (1997) Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527
104. 104. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S (1993) Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10193-10197
105. 105. Diehl JA, Hannink M (1994) Identification of a C/ EBP-Rel complex in avian lymphoid cells. Mol Cell Biol 14:6635-6646
106. 106. Perkins ND, Agranoff AB, Pascal E, Nabel GJ (1994) An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol 14:6570-6583
107. 107. Whitley MZ, Thanos D, Read MA, Maniatis T, Collins T (1994) A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol 14:6464-6475
108. 108. Lewis H, Kaszubska W, DeLamarter JF, Whelan J (1994) Cooperativity between two NF-κB complexes, mediated by high-mobility-group protein I (Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol Cell Biol 14:5701-5709
109. 109. John S, Reeves RB, Lin JX, Child R, Leiden JM, Thompson CB, Leonard WJ (1995) Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol Cell Biol 15:1786-1796
110. 110. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T (1995) Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2558-2569
111. 111. Giuliani C, Saji M, Napolitano G, Palmer LA, Taniguchi SI, Shong M, Singer DS, Kohn LD (1995) Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-κB. J Biol Chem 270:11453-11462
112. 112. Thanos D, Maniatis T (1995) Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 15:152-164
113. 113. Thanos D, Maniatis T (1995) NF-κB: a lesson in family values. Cell 80:529-532